Steven E. Canfield

The University of Texas MD Anderson Cancer Center

Papers

2

Total Citations

292

H-Index

2

About

Dr. Steven E. Canfield is a leading urologic oncologist whose research has significantly advanced the surgical management of localized renal cancer. His most impactful work, a 2012 systematic review of perioperative and quality-of-life outcomes following surgical management of localized renal cancer, has garnered 288 citations, establishing a critical evidence base for treatment decisions. This comprehensive analysis synthesized data on complications, functional recovery, and patient-reported outcomes, directly influencing clinical guidelines and helping surgeons and patients weigh options like partial versus radical nephrectomy. Dr. Canfield has also contributed to the field of robotic prostatectomy, with work on evidence-based recovery of erectile function following the procedure. His research bridges the gap between surgical technique and patient-centered outcomes, emphasizing not just cancer control but also long-term quality of life. Through his systematic reviews and clinical studies, Dr. Canfield has provided urologists with the data needed to optimize perioperative care and counsel patients effectively, making him a respected voice in urologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
292
Total Citations
146
Avg Citations/Paper
🏆 Most Cited Paper
Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer
288 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago